Status:
UNKNOWN
Study on Tear Proteins in Diabetic Retinopathy of Type 2 Diabetics
Lead Sponsor:
Dow University of Health Sciences
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
30-90 years
Brief Summary
Diabetes mellitus is becoming a global epidemic. There is a need to devise a non invasive method for detection of diabetes and its related complication. Tear proteins are easy to collect causing no ha...
Detailed Description
Diabetes mellitus causes a significant alteration in tear proteins. If we analyze tear proteins by means of electrophoresis, HPLC, and mass spectroscopy. We can find different type of tear proteins i...
Eligibility Criteria
Inclusion
- diabetic patients with type 2 diabetes
- age above 30
- willing to participate
Exclusion
- ocular surface disorders.
- collagen vascular diseases
- Limbal hyperemia
- previous ocular surgery
- creatinine level above 1.0
- liver diseases
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00698698
Start Date
January 1 2009
End Date
June 1 2011
Last Update
February 2 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dow University of Health Sciences
Karachi, Sindh, Pakistan, 75500